S
SELLAS Life Sciences Group D
D
SLS
1.55000
USD
-0.01
(-0.64%)
مغلق
حجم التداول
35,274
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
154,655,105
الأخبار المقالات
العنوان: SELLAS Life Sciences Group
القطاع: Healthcare
الصناعة: Biotechnology
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.